Related Experiment Video
Updated: May 16, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Economic and microbiologic evaluation of single-dose vial extension for hazardous drugs
Erinn C Rowe1, Scott W Savage, William A Rutala
1University of North Carolina (UNC) Health Care, Chapel Hill, NC, USA. erowe@unch.unc.edu
Purpose:
The update of US Pharmacopeia Chapter <797> in 2008 included guidelines stating that single-dose vials (SDVs) opened and maintained in an International Organization for Standardization Class 5 environment can be used for up to 6 hours after initial puncture. A study was conducted to evaluate the cost of discarding vials after 6 hours and to further test sterility of vials beyond this time point, subsequently defined as the beyond-use date (BUD).
Methods:
Financial determination of SDV waste included 2 months of retrospective review of all doses prescribed. Additionally, actual waste log data were collected. Active and control vials (prepared using sterilized trypticase soy broth) were recovered, instead of discarded, at the defined 6-hour BUD.
Results:
The institution-specific waste of 19 selected SDV medications discarded at 6 hours was calculated at $766,000 annually, and tracking waste logs for these same medications was recorded at $770,000 annually. Microbiologic testing of vial extension beyond 6 hours showed that 11 (1.86%) of 592 samples had one colony-forming unit on one of two plates. Positive plates were negative at subsequent time points, and all positives were single isolates most likely introduced during the plating process.
Conclusion:
The cost of discarding vials at 6 hours was significant for hazardous medications in a large academic medical center. On the basis of microbiologic data, vial BUD extension demonstrated a contamination frequency of 1.86%, which likely represented exogenous contamination; vial BUD extension for the tested drugs showed no growth at subsequent time points and could provide an annual cost savings of more than $600,000.
Related Concept Videos
Drug Product Stability
Clinically Relevant Drug Product Specifications: Methods of Establishment
Dosage Interval and Administration Route: Determination Methods
In Vitro Drug Release Testing: Overview, Development and Validation
Automated Microbial Diagnostics
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

